•  
  •  
  •  
  •  

2025-12-23 13:07:04

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial

Keywords Selected:  CommercialPaper

Stock Report

  • CRISIL Rating on the Rs.23.5 Crore Commercial Paper of Nahar Spinning Mills Limited
  • UGRO Capital Limited approves commercial paper issue
  • Muthoot Capital Services Ltd issued Commercial Paper of Rs.30 Crores
  • ICRA and CRISIL enhances Commercial Paper limits of Godrej Properties Ltd to INR 1750 crore
  • CRISIL reaffirms rating of Sudarshan Chemical Industries' commercial paper programme
  • Muthoot Capital Services Ltd issues Commercial Paper of Rs.30 Crores
  • CRISIL reaffirm rating of Commercial Paper Programme of PNB Gilts Ltd
  • ICRA reaffirms Commercial Paper rating of TCI Express Ltd
  • CRISIL updates on ratings of Angel One Ltd
  • CRISIL reaffirms ratings of Coromandel International Limited
  • UGRO Capital Limited raises Rs. 24 crores through Commercial Paper issue
  • CRISIL A1+ rating assigned to Commercial Paper of Prism Johnson Ltd
  • Trident Limited redeems Commercial Paper of Rs. 50 crores
  • CRISIL reaffirms Commercial Paper rating of Godrej Properties Ltd
  • CARE A1+ rating assigned to commercial paper of Atul Limited
  • CRISIL Ratings on the Rs.50 Crore Commercial Paper of Solar Industries India Limited

Latest Post

  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024